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Abstract
Purpose: The progression of synovial chondromatosis to chondrosarcoma is very rare. Distinction between these two entities
may be difficult on histology alone, and should be based on clinical, radiographic and microscopic evidence.
Immunohistochemical markers that would facilitate differentiation between synovial chondromatosis and chondrosarcoma
are currently being investigated.
Patients: We describe the cases of two patients who presented with synovial chondromatosis and progression to synovial
chondrosarcoma during periods of 7 and 11 years. Several biopsies and resected specimens demonstrated synovial
chondromatosis before a diagnosis of chondrosarcoma was made.
Method: We have examined five markers (Bcl2, Ki67, p27, p16, and p53) in all specimens from these cases, as well as known
cases of chondromatosis and chondrosarcoma for control purposes.
Results: We found increased expression of Bcl2 in benign chondromatosis compared to synovial or central chondrosarcomas.
Discussion: Distinction between chondromatosis and its progression to low grade chondrosarcoma is difficult at histological
level, and must involve incorporation of clinical and radiographical data. Although preliminary, our study suggests that
reduced or absent expression of Bcl2 is associated withmalignant transformation of ch ondromatosis.
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Introduction
Synovial chondromatosis, also known as synovial
osteochondromatosis or synovial chondrometaplasia,
is an idiopathic synovial proliferation. It is character-
ized by multiple nodules of metaplastic hyaline
cartilage within the synovial membrane of a joint,
often detaching to form intra-articular loose bodies.
1
Synovial chondrosarcoma is an uncommon malig-
nant cartilaginous neoplasm arising in synovial
tissue, withonly 34 reported cases in th e literature
to date.
2 Most show evidence of concurrent and
most likely pre-existing primary synovial chondro-
matosis, suggesting malignant transformation.
1
Documented malignant transformation of synovial
chondromatosis to chondrosarcoma is quite rare,
withapproximately 20 cases reported in th e literature
to date. The risk of progression to malignancy is
reportedly as high as 5%.
3
Patients
In 1991, a 55-year-old female presented withh istory
of progressive pain in her right hip. Plain radiography
of the pelvis and right hip was suggestive of synovial
chondromatosis (Fig. 1a). In 1992, the patient
underwent synovectomy and removal of clusters of
cartilaginous tissue, 3–4cm in size, the pathology of
which was determined to be synovial chondromatosis
(Fig. 2a).
This resection provided temporary relief of symp-
toms. The pain then worsened, necessitating another
resection in July 1994. Multiple cartilaginous
nodules were excised, and this was followed with
an arthroplasty of the right hip. The initial pathology
report suggested a low grade chondrosarcoma,
but an external consultation witha bone and soft
tissue pathologist diagnosed synovial chondromatosis
(Fig. 2b).
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In January, 1997, her pain became unbearable. CT
and ultrasound of the pelvis identified a 10 8-cm
circular mass adjacent to the right hip, as well as a
small area of calcification in the right iliac muscle
(Fig. 1b). Digital rectal examination revealed a firm
mass displacing the rectum to the left. The mass was
excised from the medial thigh in August. Grossly,
this was composed of multiple 0.3–2-cm hard
nodules. Pathology once again identified a recur-
rence of synovial chondromatosis.
The patient’s pain was unremitting, and CT now
demonstrated a mass in the iliacus muscle (5cm in
diameter) and another mass next to the acetabulum
of the right hip (4cm in diameter). CT-guided
biopsy of the smaller mass identified fragments of
hyaline cartilaginous tissue. The masses continued
to grow (Fig. 1c), and the patient underwent a
right hemipelvectomy in September 1999, for pain
control. Pathology now demonstrated the lesions to
be a low grade chondrosarcoma arising in synovial
chondromatosis (Fig. 2c). The hemipelvectomy
specimen consisted of the right leg, hip joint, and
portions of iliac bone and sacrum. A partly cystic
mass measuring 37 22 10cm without gross inva-
sion of underlying bone was noted. Multiple sections
showed numerous cartilaginous nodules composed
of chondrocytes with mild atypia and a few binu-
cleated cells. In some lobules, cellularity was more
prominent at the periphery. No mitotic figures were
present. Foci of diffuse cellularity were identified.
The stroma varied in character from chondroid to
myxoid. The diagnosis was supported by external
consultation to a pathologist with bone and soft
tissue expertise. A chest x-ray was clear.
In November 2000, the patient presented with
pain in her left hip. Ultrasound and CT found a
lesion anterior to the left pubic bone, and a wedge
Fig. 1. Sequential imaging of our case. (a) Soft tissue mass in the right hip joint. Note widening of the right hip joint (vertical arrow)
and erosion of the medial aspect of the femoral head (horizontal arrow) (frontal plain film, November 1991). (b) Large 6.0-cm soft
tissue mass medial to right hip, displacing the bladder (vertical arrow). Note beam hardening artifact from prosthetic hip (plain CT,
January 1997). (c) New, multiple, lobulated soft tissue masses adjacent to the right hip (horizontal arrows) and the irregular
‘arc and whorl’ of calcification within the most medial mass (vertical arrow). Again, note beam hardening artifact from prosthetic
hip (plain CT, May 1999). (d) Post-right hemipelvectomy. Note the new large 5.0-cm soft tissue mass in the left inguinal region
(vertical arrow) (plain CT, May 2001).
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2001, pelvic CT identified four masses in total in the
left groin area, suspicious for recurrent chondro-
sarcoma (Fig. 1d). One mass was excised, and
showed recurrent low grade chondrosarcoma.
Interestingly, a second female, aged 42 years,
presented in a similar fashion at this same institution
during the same time period. This patient progressed
from synovial chondromatosis of the left hip to chon-
drosarcoma within a period 11 years. Once again,
numerous biopsies and resected specimens revealed
a diagnosis of chondromatosis before malignancy
was diagnosed. This patient refused a left hemi-
pelvecomy for the chondrosarcoma, and also refused
biopsy of lung nodules suggestive of pulmonary
metastases.
Material and methods
We (RC and SA) blindly reviewed the histology of all
slides from the above two cases, mixed with six
known cases of chondromatosis and five known cases
of low grade (grade one and grade two) chondro-
sarcoma. We then investigated several immuno-
histochemical stains as potential discriminators of
synovial chondromatosis from chondrosarcoma. The
selected panel included Bcl2, Ki67, p27, p16 and
p53, markers of cell survival, proliferation, and cell
cycle regulators. We used the cases of known
chondromatosis and low grade chondrosarcomas to
serve as controls to make comparisons withth e
sections from our cases. All of the specimens from
eachsurgical event were used from bothof th e above
cases.
Fig. 2. Sequential photomicrographs of lesions from our
case, suggesting progression from synovial chondromatosis to
chondrosarcoma. (a) Right hip cartilaginous clusters from
1992, showing clustering of hypocellular chondrocytes within
connective tissue. The nuclei are slightly enlarged and
hyperchromatic, with no significant pleomorphism. (b) Right
hip cartilaginous clusters from 1994, showing a slight increase in
cellularity with a relative loss of clustering architecture. There
is no significant nuclear atypia. (c) Right hemipelvectomy
specimen from 1999, showing (although focally) chondrocytes
arranged in sheets, cellular crowding, and a focally myxoid
matix, but without significant nuclear atypia.
Fig. 3. Immunoperoxidase staining for Bcl-2 from our case.
(a) Synovial chondromatosis (1992), showing cytoplasmic
positivity for Bcl-2 in the chondrocytes. (b) Chondrosarcoma
(1999), showing no staining for Bcl2 in the chondrocytes.
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The paraffin blocks were cut at 4–6mm, dried
overnight at 60 C, and deparaffinized in xylene.
Subsequently, sections were rehydrated through
graded alcohols into water. Heat-induced epitope
retrieval was achieved by boiling sections in the
EDTA buffer at a pH of 8.9 in the Electorolux
microwave oven at 1000W for 20min (4 5min).
After boiling, sections were allowed to cool at room
temperature for 20min, rinsed thoroughly with
water, and placed in Tris-buffered saline (TBS)
for 5min. After washing with TBS, sections were
incubated for 30min at room temperature with
mouse anti-human antibodies against Bcl2 (clone
124, dilution 1:10, Dako Diagnostics Canada Inc,
Mississauga, ON), Ki67 (MIB-1, dilution 1:75,
Dako), p27 (clone SX53G8, dilution 1:20, Dako),
p16 (clone F-12, dilution 1:100, Dako) and p53
(clone DO7, dilution 1:50, Dako). The immuno-
staining was performed using automated immuno-
stainer (Vantana, Tucson, AZ) according to the
manufacturer’s instructions. Appropriate positive
and negative controls were used.
Results
On histological review of the two cases, the initial
resection of masses showed the diagnostic features
of chondromatosis. The resection prior to hemi-
pelvectomy in first case and a tissue biopsy con-
current witha ch est X-ray withlikely metastases in
second case showed focal slight increase in cellularity
in nodules without a significant diffuse pattern or
peripheral crowding or spindling of cells. There were
scattered binucleated cells and there was mild focal
atypia of chondrocytes characterized by slight
nuclear enlargement and hyperchromasia, sugges-
tive of probable early low grade chondrosarcoma.
However, these features fell short of criteria to make
a definitive diagnosis of chondrosarcoma. Gross and
microscopic examination of the hemi-pelvectomy
specimen of the first case showed nodular masses
with areas of myxoid change. Microscopically, there
were nodules typical of chondomatosis along with
nodules showing features of chondrosarcoma:
increased cellularity, peripheral spindling, myxoid
stroma, and chondrocytes with mild dysplasia.
No discrepancies were noted in blind review of
cases withknown ch ondromatosis and low grade
chondrosarcoma.
We performed immunohistochemical stains for
Bcl2 (a cell survival marker), ki67 (a cell proliferation
marker), p27, p16 (cell cycle regulators) and p53
(a tumor suppressor gene) to attempt to discriminate
between chondromatosis and low grade chondro-
sarcoma. Bcl2 was expressed at a relatively higher
level in four out of five cases of control chondroma-
tosis, and at a moderate level in one case. The Bcl2
protein was identified in chondrocytes at the
periphery of the nodules. Little or no expression of
Bcl2 was seen in five of six control chondrosarcomas
examined; one case showed moderate expression.
In slides from our two cases, Bcl2 was expressed
at higher levels in early specimens diagnosed as
chondromatosis; there was reduced expression
in later specimens diagnosed as chondrosarcoma
(Fig. 3a,b). The remaining markers showed
no differences in staining between synovial
chondromatosis and chondrosarcoma. Little or
no immunostaining for p27 or Ki67 was identified.
P16 showed moderate to marked staining in control
chondromatosis cases, control chondrosarcoma
cases, and slides from all specimens in bothcases,
and hence was not a useful marker. A rare cell
showed mild to moderate staining for p53.
Discussion
Chondrosarcoma arising in synovial chondromatosis
is very rare. This case illustrates the difficulties
in distinguishing recurrent chondromatosis from
malignant transformation of chondromatosis. It is
difficult to diagnose low grade chondrosarcoma
arising in chondromatosis on histology alone, as
they overlap in cyto-architectural features. In
addition, progression to chondrosarcoma is focal;
the findings may be easily missed with inadequate
sampling of tissue for microscopy. Misinterpretation
of synovial chondromatosis as a malignant lesion
is a common pitfall in pathology; conversely,
chondrosarcoma may be misinterpreted as a benign
lesion.
Histological examination of synovial chondroma-
tosis shows nodules of hyaline cartilage, composed
of chondrocytes within synovial connective tissue.
The chondrocytes are typically clustered and exhibit
variations in size and nuclear chromaticity, as well as
variable atypia. The degree of cellularity and nuclear
atypia may equal or exceed that seen in low grade
chondrosarcoma. Hence, it is very difficult to
predict which chondromatosis lesions will pro-
gress to malignancy. Manivel et al.
4 suggest that
histological features equivalent to grade two or three
central chondrosarcoma must be present before
diagnosing chondrosarcoma arising in synovial
chondromatosis.
The histopathological distinction between these
two lesions is not clear. Bertoni et al.
5 have suggested
histological criteria for the diagnosis of malignancy:
atypical chondrocytes arranged in sheets, myxoid
change in the matrix, mitotic figures, crowding and
spindling of nuclei at the periphery of the nodules,
necrosis, and permeation of bone trabeculae.
However, these criteria are unreliable; few of these
changes are present in the early stages of chondro-
sarcoma, and are often focal. It has been suggested
that the diagnosis of low grade chondrosarcoma
72 B. L. Sperling et al.should be made only in conjunction with unequi-
vocal invasion beyond the joint capsule.
2
It would be of great value to establishimmuno-
histochemical markers that could reliably differenti-
ate between synovial chondromatosis and low grade
synovial chondrosarcoma: these two entities share
clinical, radiological, and pathological features, and
histological criteria are partially subjective. This
distinction is important bothto avoid missing a
chondrosarcoma and to prevent over-diagnosis of
chondrosarcoma.
In contrast to Bovee et al.
6 who found that Bcl2
expression was significantly higher in low grade
synovial chondrosarcomas compared with synovial
chondromatosis, our results demonstrate increased
expression of Bcl2 in benign chondromatosis com-
pared to synovial or central chondrosarcomas. Our
study shows that a reduced or absent expression of
Bcl2 may be associated withmalignant transforma-
tion of chondromatosis.
In summary, distinction between chondromatosis
and its progression to low grade chondrosarcoma is
difficult at histological level, and must involve
incorporation of clinical and radiographical data.
Although preliminary, our study suggests that
modulation in the immunostaining for Bcl2 may
help differentiate between these two entities. More
extensive study is required, including more cases
and additional immunohistochemical markers.
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